1. The plaintiff's claim is dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

1. The following facts do not conflict between the parties, or can be acknowledged in full view of the purport of the entire pleadings in the entries in Gap evidence 1-1, 2, and 5.

The defendant is a company producing molecule paints, and the molecule paints is 100% powdered by dilution which does not contain solvents or dilution, and is used by melting and combining the melting from the surface of the object becoming heat.

(b) The manufacturing process of the Defendant’s decentralization consists of four processes: mixing, dispersion, crushing, and packing.

The mixing process is a process that combines various materials, such as synthetic resin, internal medicine, additives, etc. into a mixture. Diversing process is a work that makes ingredients into Hegel (gel) by heating, melting, or distributing them to a decentralizationr with the level of 180 cc, and the mination process is a work that makes them into a chip (chp) with the size of chip (chp) with the size of the hand-top and remins them into a powder form.

Additional mixing process is a mixture of additives after crushing process.

C. On October 11, 2004, the Plaintiff became a member of the Defendant and was assigned to the production team mixing process, and first, was in charge of the strike measurement work (raw materials measurement work) and was diagnosed on October 6, 2010, which was about one month, on the part of the Plaintiff. After which, the Plaintiff was diagnosed as “abscopic skin infection by a drug caught in the skin,” and thereafter, was in charge of a grassbscoping work (on the part of the raw materials so that the raw materials can be moved to the raw materials so that it can be put into the composite material).

The Plaintiff received treatment, including the stroph, for about one year and eight months after the diagnosis of the said skin infection. On July 16, 2012, the Plaintiff was diagnosed by the “nive high blood without any influence on the side” (hereinafter “the instant disease”), and was under the diagnosis on December 5, 2012, and was subject to the examination on the right and the left-hand high-speed pressure on the left-hand side, March 14, 2014, and the right-hand high-hand typology on March 28, 2014.